Prescribing summary cards

Read our Guidelines prescribing summary cards to support your best-practice prescribing of specific medicines. Items may contain pharmaceutical promotional information.

20220721 Trixeo PSC - digital

Trixeo® Aerosphere® (formoterol fumarate, glycopyrronium, and budesonide)

Commissioned and funded by AstraZeneca Limited

This promotional prescribing summary card has been developed from content provided by AstraZeneca Limited. Information intended for UK healthcare professionals only.
View Trixeo (formoterol fumarate dihydrate/ glycopyrronium/ budesonide) prescribing information and adverse event reporting information
View Bevespi (glycopyrronium/formoterol fumarate dihydrate) prescribing information and adverse event reporting information
GB-37843
Date of preparation: July 2022

Alliance Forceval PSC_digital index image

Malnutrition and FORCEVAL® Capsules

Commissioned by Alliance Pharmaceuticals Ltd

This prescribing summary card was developed from content provided by Alliance Pharma in a format developed by Guidelines Information intended for UK healthcare professionals only.
View Forceval® Capsules prescribing and adverse event reporting information.
JB-001493 June 2022

DuoResp Spiromax (budesonide:formoterol) prescribing summary card

DuoResp® Spiromax® (budesonide/formoterol)

Commissioned by Teva UK Limited

This promotional prescribing summary card has been developed from content provided by Teva UK Limited. Information intended for UK healthcare professionals only.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Teva UK Limited on 0207 540 7117 or medinfo@tevauk.com.

Click here for prescribing information and adverse event reporting

DUOR-GB-00117
Date of preparation: March 2022